EGFR and colorectal carcinoma: Recent studies have shown that the RNA-binding protein RALY promotes OXPHOS activation and mitochondrial metabolic remodeling by regulating microRNA processing, thereby enhancing the adaptive capacity of CRC cells to EGFR or MEK inhibition [9].